company-creation
(2)
Errik Anderson
Errik Anderson is the founder and CEO of Alloy Therapeutics, a Lexington, Massachusetts biotech he built around a single idea: stop selling drugs and start selling access to the tools that make them. A bioengineer and serial entrepreneur, he has founded or co-founded seven venture-backed biotech companies - Adimab, Alloy, Compass Therapeutics, Alector, Arsanis, and Avitide among them - whose technologies have helped discover more than 90 therapeutic antibodies now approved or in FDA review. Alloy reinvests 100% of its revenue into science and, by design, can never be sold. Outside the lab, Anderson co-owns the New England Free Jacks pro rugby team and has chaired Major League Rugby's Board of Governors.
Beckie Robertson
Beckie Robertson is co-founder and general partner at Versant Ventures, a San Francisco-based venture capital firm focused on biotechnology and drug discovery. A chemical engineer by training, she has spent decades backing early-stage medical device and diagnostics companies, with prior operating roles at Chiron Diagnostics, Lifescan, and Egis. She currently serves as vice chair of the Cornell Board of Trustees and was awarded the Cornell Duffield Engineering Distinguished Alumni Award in April 2026.